MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ckj/sfad152

Медицинская библиотека · Clinical kidney journal · 2023

Opportunities to improve the management of anemia in peritoneal dialysis patients: lessons from a national study in routine clinical practice.

Portoles Jose, Serrano Salazar Maria Luisa, González Peña Olga, Gallego Domínguez Sandra, Vera Rivera Manel, Caro Espada Jara, Herreros García Alba, Munar Vila Maria Antonia, José Espigares Huete Maria, Sosa Barrios Haridian, Paraíso Vicente, Mariscal de Gante Loreto, Bajo Maria Auxiliadora, Mijaylova Antonia Gueorguieva, Pascual Pajares Elena, Areste Fosalba Nuria, Espinel Laura, Tornero Molina Fernando, Pizarro Sánchez Soledad, Ortega Díaz Mayra, Cases Aleix, Quiroga Borja

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Current guidelines establish the same hemoglobin (Hb) and iron biomarkers targets for hemodialysis (HD) and peritoneal dialysis (PD) in patients receiving erythropoiesis-stimulating agents (ESAs) even though patients having PD are usually younger, more active and less comorbid. Unfortunately, specific renal anemia [anemia in chronic kidney disease (aCKD)] trials or observational studies on PD are scanty. The aims of this study were to describe current aCKD management, goals and adherence to clinical guidelines, identifying opportunities for healthcare improvement in PD patients.

METHODS

This was a retrospective, nationwide, multicentre study including patients from 19 PD units. The nephrologists collected baseline data, demographics, comorbidities and data related to anemia management (laboratory values, previously prescribed treatments and subsequent adjustments) from electronic medical records. The European adaptation of KDIGO guidelines was the reference for definitions, drug prescriptions and targets.

RESULTS

A total of 343 patients (mean age 62.9 years, 61.2% male) were included; 72.9% were receiving ESAs and 33.2% iron therapy [20.7% intravenously (IV)]. Eighty-two patients were receiving ESA without iron therapy, despite 53 of them having an indication according to the European Renal Best Practice guidelines. After laboratory results, iron therapy was only started in 15% of patients. Among ESA-treated patients, 51.9% had an optimal control [hemoglobin (Hb) 10-12 g/dL] and 28.3% between 12-12.9 g/dL. Seventeen patients achieved Hb >13 g/dL, and 12 of them remained on ESA after overshooting. Only three patients had Hb <10 g/dL without ESAs. Seven patients (2%) met criteria for ESA resistance (epoetin dose >300 IU/kg/week). The highest tertile of erythropoietin resistance index (>6.3 UI/kg/week/g/dL) was associated with iron deficiency and low albumin corrected by renal replacement therapy vintage and hospital admissions in the previous 3 months.

CONCLUSION

Iron therapy continues to be underused (especially IV). Low albumin, iron deficiency and prior events explain most of the ESA hyporesponsiveness. Hb targets are titrated to/above the upper limits. Thus, several missed opportunities for adequate prescriptions and adherence to guidelines were identified.

Для цитирования: Portoles Jose, Serrano Salazar Maria Luisa, González Peña Olga, Gallego Domínguez Sandra, Vera Rivera Manel, Caro Espada Jara, Herreros García Alba, Munar Vila Maria Antonia, José Espigares Huete Maria, Sosa Barrios Haridian, Paraíso Vicente, Mariscal de Gante Loreto, Bajo Maria Auxiliadora, Mijaylova Antonia Gueorguieva, Pascual Pajares Elena, Areste Fosalba Nuria, Espinel Laura, Tornero Molina Fernando, Pizarro Sánchez Soledad, Ortega Díaz Mayra, Cases Aleix, Quiroga Borja. Opportunities to improve the management of anemia in peritoneal dialysis patients: lessons from a national study in routine clinical practice.. Clinical kidney journal. 2023. DOI: 10.1093/ckj/sfad152.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.